e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Control of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New methodologogic approaches to the management of antituberculous service
A. Svistelnic, V. Krasnov, I. Kalachov, L. Pogozheva, D. Stepanov (Novosibirsk, Russia)
Source:
Annual Congress 2003 - Control of tuberculosis
Session:
Control of tuberculosis
Session type:
Oral Presentation
Number:
2459
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Svistelnic, V. Krasnov, I. Kalachov, L. Pogozheva, D. Stepanov (Novosibirsk, Russia). New methodologogic approaches to the management of antituberculous service. Eur Respir J 2003; 22: Suppl. 45, 2459
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
New perspectives in MDR-TB management
Source: International Congress 2016 – China Session II
Year: 2016
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
New guidelines to manage MDR-TB
Source: School Course 13
Year: 2013
New experiences from global use of new tools in TB management and control
Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Year: 2013
New perspectives in PGD prevention and treatment
Source: School Course 2012 - Lung Transplantation
Year: 2012
Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance
Source: Eur Respir J 2012; 39: 802-804
Year: 2012
New antibiotics into clinical practice
Source: Annual Congress 2004 - PG18 - Childhood pneumonia after the turn of the new millennium
Year: 2004
Management of drug resistant pulmonary TB. New problems and perspectives
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009
New anti-tuberculosis drugs and regimens: 2015 update
Source: ERJ Open Res 2015; 1: 00010-2015
Year: 2015
New anti-tuberculosis drugs for special populations: a difficult-to-address issue
Source: Eur Respir J 2016; 48: 957-958
Year: 2016
New frontiers in the management of asthma
Source: International Congress 2017 – State of the art session: "Paediatric"
Year: 2017
Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care
Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features
Year: 2012
Better diagnostics for targeted antibiotic therapy
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020
Excellency of anti-tuberculosis primary care: an evidence-based medicine challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 142s
Year: 2005
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
New and repurposed TB drugs use in children and adolescents with M/XDR-TB
Source: International Congress 2017 – Treatment of multi-drug-resistant tuberculosis (MDRTB): where are we now?
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept